It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.
It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.
<iframe src="https://statesidedaily.com/embed/cluster/fb162d50095d905039829e8394e45dc0452b22ff" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews"></iframe>
It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.
